UTHR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - United Therapeutics Corp

Watchlist Manager

Watchlist

Price: 492.29 USD -3.98% Market Closed

Market Cap: $20.9B

	United Therapeutics Corp NASDAQ:UTHR	US
S	Sensient Technologies Corp F:SSF	US
	Essential Properties Realty Trust Inc F:2OU	US
I	Illumina Inc XBER:ILU	US
	Molson Coors Canada Inc OTC:MXGBF	CA

Profitability Summary

United Therapeutics Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

88%

Declining Gross Margin

90% > 86%

Exceptional Operating Margin

44%

Strong 3Y Average Operating Margin

49%

Declining Operating Margin

52% > 44%

Exceptional Net Margin

42%

Strong 3Y Average Net Margin

41%

Net Margin is Increasing

41% > 42%

Exceptional Free Cash Flow Margin

34%

Strong 3Y Average Free Cash Flow Margin

34%

Free Cash Flow Margin is Increasing

32% > 34%

Positive ROE

19%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

28%

ROIC is Increasing

25% > 28%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.